Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design.
about
Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development.Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken designOptimization of a validated stability-indicating RP-LC method for the determination of fulvestrant from polymeric based nanoparticle systems, drugs and biological samples.Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken designEvaluation of anticancer drug-loaded nanoparticle characteristics by nondestructive methodologies.Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.Nanomedicine for uterine leiomyoma therapyPreparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model.Development and statistical optimization of nefopam hydrochloride loaded nanospheres for neuropathic pain using Box-Behnken design.Fabrication and optimization of camptothecin loaded Eudragit S 100 nanoparticles by Taguchi L4 orthogonal array design.Poly ɛ-caprolactone nanoparticles loaded with Uncaria tomentosa extract: preparation, characterization, and optimization using the Box-Behnken design.Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach.Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride.Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.Impact of microparticle formulation approaches on drug burst release: a level A IVIVC.Quality-by-design approach for the development of telmisartan potassium tablets.Preparation and Characterization of PLGA Encapsulated Protective Antigen Domain 4 Nanoformulation.Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach.Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE) - inhibitory biopeptides by chitosan nanoparticles optimized using Box-Behnken design.Optimization of protein loaded PLGA nanoparticle manufacturing parameters following a quality-by-design approach
P2860
Q34005835-9756C229-21F1-4D83-8BE9-F03228AE883CQ34883416-B2041924-32F0-4440-BA1C-4DD05AD88164Q35174210-2FAC5EA5-E74C-4011-89B3-59B70184766FQ35796474-81257C2F-810B-4AAF-B66E-F12857825CEDQ35999089-3F59ACF1-E43A-4C7E-956C-39BF192BA500Q37003811-968CF287-0B91-440B-BCC3-4FA098FBF9E7Q37124426-9FE84B5C-2351-430F-8E70-A5D30592CFDDQ37238557-28F15932-8000-4151-BC35-407B975969E7Q37330760-96F26A22-EA94-4539-B7A0-4FC80DC30A57Q40642201-D1FDD5CF-863D-4011-9B76-7D3CBA0E900BQ41843230-1E947B31-90FA-4803-BA65-EDA468A1DDC3Q42056839-7CA79C99-BC32-43C0-B458-3F3F81DD3CA6Q42091649-E22EA42D-6FED-4F47-B184-5A8688920799Q43978588-BFFAAE4F-1063-45D8-B137-4DBFF7A9870DQ46647863-B5AF1B44-6D80-481A-9C69-4F7912D67EB0Q46897568-0E512701-1C8D-46D4-BAB7-36F629EC2100Q47751045-694295B3-3022-40DE-A722-11CC1F702BE0Q51372190-40CEF451-4977-4097-822A-42A41B5B4B25Q53686493-6549DF42-441E-4E08-817A-D2CAAE6A7222Q54607427-A414A2D6-30C5-455E-82C4-12F6D030A75AQ55668817-7697DF68-1187-4AAA-A5F4-6AB7CC028D8BQ57656129-2B249934-0583-4E74-B6A7-B7E6A5A5BBD8
P2860
Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Understanding the quality of p ...... ity by Plackett-Burman design.
@en
Understanding the quality of p ...... ity by Plackett-Burman design.
@nl
type
label
Understanding the quality of p ...... ity by Plackett-Burman design.
@en
Understanding the quality of p ...... ity by Plackett-Burman design.
@nl
prefLabel
Understanding the quality of p ...... ity by Plackett-Burman design.
@en
Understanding the quality of p ...... ity by Plackett-Burman design.
@nl
P2093
P2860
P1476
Understanding the quality of p ...... ity by Plackett-Burman design.
@en
P2093
Ahmed S Zidan
Mansoor A Khan
Muhammad J Habib
P2860
P304
P356
10.1016/J.IJPHARM.2009.12.040
P407
P577
2009-12-29T00:00:00Z